FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Compound Preferred, LLC(014579844)" | Bevacizumab | 1.25 mg/.05 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Podophyllum Resin; Cantharidin; Salicylic Acid | 50 mg/1 mL; 10 mg/1 mL; 300 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Bevacizumab | 1.25 mg/.05 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Procaine Hydrochloride | 20 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Ranibizumab | .5 mg/.05 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Squaric Acid Dibutyl Ester | 20 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Brolucizumab | 6 mg/.05 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Brolucizumab | 6 mg/.05 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Tetracaine Hydrochloride | 5 mg/1 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Tetracaine Hydrochloride | 40 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Tetracaine Hydrochloride; Epinephrine Bitartrate; Lidocaine Hydrochloride | 5 mg/1 g; .5 mg/1 g; .04 g/1 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Tetracaine Hydrochloride; Epinephrine Bitartrate; Lidocaine Hydrochloride | 5 mg/1 g; .5 mg/1 g; .04 g/1 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Tranexamic Acid | 50 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Vancomycin Hydrochloride | 1000 ug/.1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Cantharidin | 7 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Cantharidin | 7 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Ceftazidime | 2250 ug/.1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Dexamethasone Sodium Phosphate | 400 ug/.1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Dyclonine Hydrochloride | 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Dyclonine Hydrochloride; Lidocaine Hydrochloride | 10 mg/1 mL; 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Aflibercept | 2 mg/.05 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 40 mg/1 mL; 40 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Benzocaine | .06 g/1 g; .04 g/1 g; .2 g/1 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 200 mg/1 g; 40 mg/1 g; 20 mg/1 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 100 mg/1 g; 40 mg/1 g; 100 mg/1 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine; Tetracaine | .23 g/1 g; .07 g/1 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Compound Preferred, LLC(014579844)" | Lidocaine; Tetracaine | 40 mg/1 g; 100 mg/1 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 5 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-022 | 71449-022-32 | Morphine Sulfate | 5 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-021 | 71449-021-11 | Morphine Sulfate | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 5 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-103 | 71449-103-11 | Neostigmine Methylsulfate | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-015 | 71449-015-06 | Atropine Sulfate | .4 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-001 | 71449-001-15 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-091 | 71449-091-43 | Bevacizumab | 25 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-091 | 71449-091-44 | Bevacizumab | 25 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-004 | 71449-004-11 | Rocuronium Bromide | 10 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-091 | 71449-091-35 | Bevacizumab | 25 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-070 | 71449-070-31 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-124 | 71449-124-83 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-079 | 71449-079-55 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-079 | 71449-079-57 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-079 | 71449-079-51 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-079 | 71449-079-59 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-105 | 71449-105-15 | Succinylcholine Chloride | 20 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-105 | 71449-105-11 | Succinylcholine Chloride | 20 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "Denver Solutions, LLC dba Leiters Health(080586798)" | 71449-126 | 71449-126-15 | Succinylcholine Chloride | 20 mg/1 mL | 2020-2 | valid | 2026-11-12 |